CYCLIC-AMP SELECTIVELY ENHANCES BRADYKININ RECEPTOR SYNTHESIS AND EXPRESSION IN CULTURED ARTERIAL SMOOTH-MUSCLE - INHIBITION OF ANGIOTENSIN-II AND VASOPRESSIN RESPONSE
Bs. Dixon, CYCLIC-AMP SELECTIVELY ENHANCES BRADYKININ RECEPTOR SYNTHESIS AND EXPRESSION IN CULTURED ARTERIAL SMOOTH-MUSCLE - INHIBITION OF ANGIOTENSIN-II AND VASOPRESSIN RESPONSE, The Journal of clinical investigation, 93(6), 1994, pp. 2535-2544
Bradykinin receptors on vascular smooth muscle may play an important r
ole in regulating the endogenous effects of the vascular kallikrein-ki
nin system. The present study examined the effect of cyclic nucleotide
s on bradykinin-stimulated responses in cultured arterial smooth muscl
e cells. Short term stimulation (1 min) with cyclic AR IP produced a v
ariable inhibition of bradykinin-stimulated calcium mobilization which
was lost in later passaged cells. However, long-term stimulation (24
h) produced a consistent increase in bradykinin-stimulated calcium mob
ilization in both early and late passaged cells. Further analysis demo
nstrated that chronic exposure to cAMP produced a twofold increase in
both the number of cell surface bradykinin receptors and in bradykinin
-stimulated phosphoinositide hydrolysis. The increase in bradykinin re
ceptors was time dependent (> 7 h) and blocked by protein synthesis in
hibitors, suggesting that cAMP enhanced the synthesis of new bradykini
n receptors. The increase in bradykinin receptor binding and calcium m
obilization was also stimulated by cholera toxin, forskolin, and isobu
tylmethylxanthine, but not isoproterenol or prostaglandin E(2). Of con
siderable interest, prolonged exposure to cAMP inhibited both angioten
sin II and arginine vasopressin-stimulated phosphoinositide hydrolysis
and intracellular calcium mobilization. In summary, prolonged treatme
nt with cAMP selectively stimulates the synthesis and expression of br
adykinin receptors on arterial smooth muscle while decreasing the resp
onsiveness to vasoconstrictor agonists such as angiotensin II and vaso
pressin.